Home › Asset managers › Compare 2025-2026 › Equitable vs Prudential/PGIM
Equitable 2025-2026 · Prudential/PGIM 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 26,688 | 21,052 | 924 | 4,712 | 95.8% | 89.3% |
| Board proposals | 24,319 | 19,234 | 851 | 4,234 | 95.8% | 89.4% |
| E&S shareholder proposals | 196 | 96 | 3 | 97 | 97.0% | 82.8% |
| Other items | 2,173 | 1,722 | 70 | 381 | 96.1% | 88.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
5,085 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Equitable | Prudential/PGIM |
|---|---|---|---|---|---|---|
| 1stdibs.com, Inc. | May 7, 2026 | The election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Matthew R. Cohler Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The approval of the amendment and restatement of the 2015 Incentive Plan to increase the number of shares reserved for issuance thereunder by 4,000,000 shares and to extend the term until 2036. Compensation |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| A-MARK PRECIOUS METALS, INC. | November 12, 2025 | Advisory vote on executive compensation Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| ABACUS GLOBAL MANAGEMENT, INC. | June 3, 2026 | Approval, by an advisory vote, of the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 3 funds |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: James M. Daly Director Elections |
Board | For | WITHHOLD 3 funds |
FOR 4 funds |
| ACNB CORPORATION | May 5, 2026 | To elect four (4) Class 3 directors to serve for terms of three (3) years and until their successors are elected and qualified. Kimberly S. Chaney Director Elections |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| ADTALEM GLOBAL EDUCATION INC. | November 12, 2025 | Say-on-pay: Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| ADTRAN Holdings, Inc. | July 24, 2025 | Election of Directors: Balan Nair Director Elections |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| AEBI SCHMIDT HOLDING AG | May 21, 2026 | Election of Barend Fruithof as the Chair of the Board of Directors Corporate Governance |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| AEHR TEST SYSTEMS | October 20, 2025 | Proposal to approve an amendment to the Company's 2023 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by an additional 2,500,000 shares of common stock Compensation |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| AEHR TEST SYSTEMS | October 20, 2025 | Proposal to approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| AERCAP HOLDINGS N.V. | April 15, 2026 | Authorization of the Board of Directors to limit or exclude pre-emptive rights in relation to agenda item 10(a). Shareholder Rights and Defenses |
Board | For | FOR 1 fund |
AGAINST 14 funds |
| AERSALE CORPORATION | June 11, 2026 | Approval, on an advisory basis, of the Company's named executive officer compensation. Compensation |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| AGENUS INC. | June 16, 2026 | To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers for 2025 (Say-on-Pay). Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| AGILON HEALTH, INC. | June 2, 2026 | Approval, by advisory vote, of the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| AIRGAIN INC | June 10, 2026 | To approve the amendment and restatement of the 2016 Incentive Award Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| AIRGAIN INC | June 10, 2026 | To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| ALBANY INTERNATIONAL CORP. | May 15, 2026 | To approve, by non-binding advisory vote, executive compensation Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| ALDEYRA THERAPEUTICS, INC. | June 9, 2026 | To approve, on a non-binding, advisory basis, the compensation of Aldeyra Therapeutics, Inc.'s named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| ALIMENTATION COUCHE-TARD INC | September 3, 2025 | ELECTION OF DIRECTOR: MELANIE KAU Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 3 funds |
| ALKAMI TECHNOLOGY INC | May 19, 2026 | To elect the three nominees for director named herein to serve as Class II directors to hold office until the 2029 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified. Charles Kane Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| ALLY FINANCIAL INC. | May 6, 2026 | Advisory Vote to Ratify Named Executive Officers' Compensation Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 10 funds |
| AMBARELLA, INC. | June 26, 2026 | To approve an amendment and restatement of the Ambarella, Inc. 2021 Equity Incentive Plan. Compensation |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| AMERESCO, INC. (AMRC) | June 4, 2026 | To approve on a non-binding advisory basis the compensation of our named executive officer as described in the Ameresco, Inc. Proxy Statement. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 2 funds |
| AMTECH SYSTEMS, INC. | March 4, 2026 | Election of Directors: Asif Jakwani Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| AMTECH SYSTEMS, INC. | March 4, 2026 | Election of Directors: Michael Garnreiter Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| AMTECH SYSTEMS, INC. | March 4, 2026 | Election of Directors: Michael M. Ludwig Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| AMTECH SYSTEMS, INC. | March 4, 2026 | To approve the advisory (non-binding) resolution relating to the named executive officer compensation as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| AMYLYX PHARMACEUTICALS, INC. | June 4, 2026 | Election of Directors: To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: George Mclean Milne Jr., Ph.D. Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| ANHUI CONCH CEMENT CO LTD | May 28, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| ANZ GROUP HOLDINGS LIMITED | December 18, 2025 | Approve Remuneration Report Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 6 funds |
| ARCBEST CORPORATION | April 24, 2026 | To approve the reincorporation of the Company to the State of Texas by conversion. Extraordinary Transactions |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| ARCUS BIOSCIENCES, INC. | June 11, 2026 | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| ARQ, INC. | June 10, 2026 | To approve the Arq, Inc. 2026 Omnibus Incentive Plan; and Compensation |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| ARRAY DIGITAL INFRASTRUCTURE, INC. | October 9, 2025 | Advisory vote to approve executive compensation Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| ARRAY TECHNOLOGIES, INC. | May 19, 2026 | Approval, on an advisory basis, of our named executive officer compensation. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| ATEA PHARMACEUTICALS, INC. | June 18, 2026 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| ATYR PHARMA, INC | May 11, 2026 | To approve an amendment to the aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan, as amended: Compensation |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| ATYR PHARMA, INC | May 11, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers; Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| ATYR PHARMA, INC | May 11, 2026 | To elect three Class II directors, as nominated by the Company's Board of Directors (the "Board of Directors"), to hold office until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified; Eric Benevich Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 1 fund |
| AUDIOEYE, INC. | June 22, 2026 | To approve, by non-binding advisory vote, the compensation of AudioEye, Inc.'s named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| Abivax SA | May 11, 2026 | Approve Compensation Report Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Approve Compensation Report of Corporate Officers Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Approve Compensation of Marc de Garidel, CEO Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Approve Compensation of Sylvie Gregoire, Chairwoman of the Board Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 750,000 Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Approve Issuance of Equity or Equity-Linked Securities for Qualified Investors, up to Aggregate Nominal Amount of EUR 237,873.56 Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Approve Issuance of Warrants (Bons) Reserved for Services Providers, Consultants, Employees and Executives, up to 10 Percent of Issued Share Capital Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Approve Remuneration Policy of CEO Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Approve Remuneration Policy of Chairwoman of the Board Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize Capital Increase of Up to EUR 750,000 for Future Exchange Offers Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize Capital Increase of up to 20 Percent of Issued Capital for Contributions in Kind Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize up to 10 Percent of Issued Capital for Use in Restricted Stock Plans Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize up to 10 Percent of Issued Capital for Use in Stock Option Plans Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Reelect June Lee as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Reelect Sylvie Gregoire as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Reelect Troy Ignelzi as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Aclaris Therapeutics, Inc. | June 4, 2026 | Election of Directors: Maxine Gowen, Ph.D. Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Acushnet Holdings Corp. | June 8, 2026 | Election of the following nominees for director: David Maher Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| Acushnet Holdings Corp. | June 8, 2026 | Election of the following nominees for director: Ho Yeon (Aaron) Lee Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| Acushnet Holdings Corp. | June 8, 2026 | Election of the following nominees for director: Keun Chang (Kevin) Yoon Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| Akebia Therapeutics, Inc. | June 17, 2026 | Election of three Class III Directors to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: Adrian Adams Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 1 fund |
| Aldeyra Therapeutics, Inc. | June 9, 2026 | Election of one Class III Director: Todd C. Brady, M.D., Ph.D. Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Daniel E. Coughlin Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Galen G. Vetter Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Janet O. Estep Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Jeffrey W. Bolton Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: John Uribe Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Katie A. Lorenson Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Mary E. Zimmer Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Nikki L. Sorum Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Randy L. Newman Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Allianz SE | May 7, 2026 | Authority to Issue Convertible Debt Instruments; Increase in Conditional Capital Capital Structure |
Board | For | FOR 1 fund |
AGAINST 12 funds |
| Alphabet Inc. | June 5, 2026 | Election of Directors: John L. Hennessy Director Elections |
Board | For | AGAINST 1 fund |
FOR 34 funds |
| Alstom | July 10, 2025 | Authority to Issue Performance Shares Capital Structure |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| Amdocs Limited | January 30, 2026 | Election of Directors: Yvette Kanouff Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Amerant Bancorp Inc. | June 2, 2026 | To elect the directors to serve until the 2027 annual meeting of shareholders: Millar Wilson Director Elections |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| Ameresco, Inc. | June 4, 2026 | To approve an amendment to Ameresco's 2020 Stock Incentive Plan ("Plan) to increase the number of shares of Ameresco, Inc. Class A Common Stock authorized for issuance under the Plan by 3,200,000 from 5,000,000 to 8,200,000 as described in the Ameresco, Inc. Proxy Statement. Compensation |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| AmeriServ Financial, Inc. | July 29, 2025 | An advisory vote to approve the compensation of the named executive officers of the Company (Matter No. 2); Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Amprius Technologies, Inc. | June 11, 2026 | Election of Class I Directors: Thomas M. Stepien Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| Anheuser-Busch Inbev SA/NV | April 29, 2026 | Remuneration Policy Compensation |
Board | For | AGAINST 1 fund |
FOR 13 funds |
| Anheuser-Busch Inbev SA/NV | April 29, 2026 | Remuneration Report Compensation |
Board | For | AGAINST 1 fund |
FOR 13 funds |
| Annexon, Inc. | June 11, 2026 | To elect the two nominees for director to serve as Class III directors to hold office until the 2029 annual meeting of stockholders: Bettina M. Cockroft, M.D. Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| Antero Midstream Corporation | June 3, 2026 | Class I Nominees: Janine J. McArdle Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| Antero Midstream Corporation | June 3, 2026 | Class I Nominees: Peter A. Dea Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| Ardent Health, Inc. | May 20, 2026 | Election of Directors: Ellen Havdala Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| Asahi Group Holdings Ltd. | March 24, 2026 | Approve Allocation of Income, with a Final Dividend of JPY 26 Capital Structure |
Board | For | FOR 9 funds |
AGAINST 6 funds |
| Ashtead Group plc | September 2, 2025 | Authority to Issue Shares w/o Preemptive Rights Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Ashtead Group plc | September 2, 2025 | Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment) Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Ashtead Group plc | September 2, 2025 | Elect Angus Cockburn Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Assa Abloy AB | April 28, 2026 | Adoption of Share-Based Incentives (LTIP 2026) Compensation |
Board | For | AGAINST 1 fund |
FOR 7 funds |
| Assa Abloy AB | April 28, 2026 | Election of Directors Director Elections |
Board | For | AGAINST 1 fund |
FOR 7 funds |
| AstraZeneca plc | April 9, 2026 | Authority to Issue Shares w/o Preemptive Rights Capital Structure |
Board | For | FOR 1 fund |
AGAINST 9 funds |
| AstraZeneca plc | April 9, 2026 | Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment) Capital Structure |
Board | For | FOR 1 fund |
AGAINST 9 funds |
Page 1 of 51 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.